Literature DB >> 29103823

Multiple sclerosis genetics: Results from meta-analyses of candidate-gene association studies.

Kalthoum Tizaoui1.   

Abstract

As a complex disease, multiple sclerosis (MS) susceptibility implicates many genetic and environmental factors. Usually, individual genetic association studies have several limitations, and results are specific to the population of study. The Meta-analysis approach has been proposed to resolve these limitations and to increase the power of statistical analyses. In this review, we summarize results from meta-analyses of candidate genes of MS. Using the keywords: multiple sclerosis, genetic polymorphism and meta-analysis, we searched electronic databases (PubMed, Embase and Web of Sciences) for published meta-analyses until May 2017. Meta-analyses confirmed the association of polymorphisms in fifteen candidate genes with MS disease. However, polymorphisms in fourteen genes showed none significant association. Results outlined the importance of confirmed genes to understand signaling pathways in MS disease and shed light on their utility to develop new drugs targets.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genetic association; Meta-analysis; Multiple sclerosis; Single nucleotide polymorphism

Mesh:

Year:  2017        PMID: 29103823     DOI: 10.1016/j.cyto.2017.10.024

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

1.  Gene variants of adhesion molecules predispose to MS: A case-control study.

Authors:  Efthimios Dardiotis; Elena Panayiotou; Vasileios Siokas; Athina-Maria Aloizou; Kyproula Christodoulou; Andreas Hadjisavvas; Marios Pantzaris; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Theodoros Kyriakides
Journal:  Neurol Genet       Date:  2019-01-16

Review 2.  Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches.

Authors:  Rashad Hussain; Hira Zubair; Sarah Pursell; Muhammad Shahab
Journal:  Brain Sci       Date:  2018-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.